Anson Funds Management LP Spero Therapeutics, Inc. Transaction History
Anson Funds Management LP
- $420 Million
- Q1 2025
A detailed history of Anson Funds Management LP transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Anson Funds Management LP holds 3,798,932 shares of SPRO stock, worth $10 Million. This represents 0.65% of its overall portfolio holdings.
Number of Shares
3,798,932
Previous 7,638,818
50.27%
Holding current value
$10 Million
Previous $5.5 Million
50.26%
% of portfolio
0.65%
Previous 1.0%
Shares
10 transactions
Others Institutions Holding SPRO
# of Institutions
43Shares Held
14.4MCall Options Held
9.3KPut Options Held
100-
Vanguard Group Inc Valley Forge, PA1.76MShares$4.66 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$3.57 Million14.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny971KShares$2.56 Million0.0% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$2.35 Million0.06% of portfolio
-
Murchinson Ltd. Toronto, A6874KShares$2.31 Million0.08% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $92.6M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...